+1 617 937 2321 ljacobs@cooley.com
Layne Jacobs assists clients with a broad range of business activities, including M&A, private and public financings, securities law compliance and corporate governance.
Download full bio
Turnstone Biologics Acquisition of Myst Therapeutics
Inventiva – $108 Million IPO
Zentalis Pharmaceuticals - $190 Million IPO
Milestone Pharmaceuticals – $95 Million IPO
Datto Agrees to Sale with Vista Equity Partners, Merger with Autotask
View all
Harvard Law SchoolJD, 2014
Yale UniversityPhD, Religious Studies2014
Duke Divinity SchoolMTS
Southern Nazarene UniversityBA
Massachusetts
Datto Agrees to Sale with Vista Equity Partners, Merger with Autotask October 31, 2017
EnerNOC Sells to Enel Group for More Than $300 Million June 29, 2017
North Bridge Growth Equity Leads Growth Equity Investment in Lucid April 12, 2017
+1 617 937 2321 office ljacobs@cooley.com
500 Boylston Street14th FloorBoston, MA 02116-3736